You cannot get HPV from toilet seats, hugging or holding hands, swimming in pools or hot tubs, or sharing food or utensils. Anyone who is sexually active can get HPV, even if they have had sex with only one person.

GARDASIL 9 helps protect individuals ages 9 to 45 against the following diseases caused by 9 types of HPV: cervical, vaginal, and vulvar cancers in females, anal cancer, certain head and neck cancers, such as throat and back of mouth cancers and genital warts in both males and females.

Gardasil contains particles that act in some ways like HPV particles, which helps the body to recognize HPV particles in case of infection and develop an immune response.

What are the ingredients in GARDASIL? The ingredients are proteins of HPV Types 6, 11, 16, and 18, amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, polysorbate 80, sodium borate, and water for injection. This leaflet is a summary of information about GARDASIL.

All preteens need HPV vaccination, so they are protected from HPV infections that can cause cancer later in life. Teens and young adults through age 26 years who didn't start or finish the HPV vaccine series also need HPV vaccination.

HPV vaccination is preventing cancer-causing infections and precancers. HPV infections and cervical precancers (abnormal cells on the cervix that can lead to cancer) have dropped since 2006, when HPV vaccines were first used in the United States.

HPV vaccination is cancer prevention. HPV is estimated to cause nearly 36,500 cases of cancer in men and women every year in the United States. HPV vaccination can prevent 33,700 of these cancers by preventing the infections that cause them.

For persons 15 through 45 years of age, GARDASIL 9 is given using a 3-dose schedule; the second shot should be given 2 months after the first shot and the third shot should be given 6 months after the first shot.

All three HPV vaccines protect against HPV types 16 and 18 that cause most HPV cancers. Since late 2016, only Gardasil-9 (9vHPV) is distributed in the United States. This vaccine protects against nine HPV types (6, 11, 16, 18, 31, 33, 45, 52, and 58).

Like other immunizations that guard against viral infection, HPV vaccines stimulate the body to produce antibodies that, in future encounters with HPV, bind to the virus and prevent it from infecting cells. The current HPV vaccines are based on virus-like particles (VLPs) that are formed by HPV surface components.

About HPV Vaccines 9-valent HPV vaccine (Gardasil-9 [23 pages]) is a non-infectious recombinant vaccine prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58.

HPV vaccination is cancer prevention. HPV is estimated to cause nearly 36,500 cases of cancer in men and women every year in the United States. HPV vaccination can prevent 33,700 of these cancers by preventing the infections that cause them.